Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), by Drug Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, and Others), by Therapeutic

Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), by Drug Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, and Others), by Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous Systems Disorders, Infectious Disorders, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

An injectable is a compounded medication to be administered into the body via a needle and syringe by several route of administration such as Intravascular (IV), Subcutaneous (SC), Intramuscular (IM), and others. Sterile injectables are used for the treatment of several disorders and diseases such as (Cardio vascular diseases, Central nervous system disorder, metabolic disorders, and others).
Market Dynamics
Increasing preference of sterile injectables over conventional drugs due to high absorbability and quick therapeutic response in body is expected to increase demand for sterile injectables over the forecast period. This has encouraged the pharmaceutical industry to emphasize on biologics and develop more products. For instance, in June 2017, Baxter entered into an agreement with Dorizoe Lifesciences (a global contract research and development (R&D) organization), engaged in developing over 20 generic injectables products in pipeline, which includes anti-infective, oncolytics, and cardiovascular medicines. Under the agreement Dorizoe will perform certain product development activities with Baxter, and Baxter will hold worldwide manufacturing and commercialization rights. This partnership is expected to expand Baxter’s pipeline of generic injectables, and strengthen its portfolio with a broad range of high-quality essential medicines.
Growing prevalence of chronic illnesses such as cancer is expected to drive global sterile injectables market growth over the forecast period. For instance, according to the Cancer Research UK in 2021, around 17 million people suffered from cancer in Europe. Moreover, according to the World Health Organization (WHO) 2021, 18.1 million people globally suffered from cancer and 9.8 million were reported to die due to cancer. This increasing prevalence is expected to increase demand for sterile injectables, which is further expected to propel the global sterile injectables market growth over the forecast period.
Key features of the study:
This report provides in-depth analysis of the global sterile injectables market, which provides market size (US$ Billion) and cumulative annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or product approvals, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global sterile injectables market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Baxter International Inc., AstraZeneca plc, Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., Gilead Sciences, Inc., JHP Pharmaceuticals, Pfizer Inc., Fresenius Kabi Ag, CordenPharma, and Hikma Pharmaceuticals PLC.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, end user upgrades, market expansions, and marketing tactics
The global sterile injectables market report caters to various stakeholders in this industry, including investors, device/system manufacturers, distributors and suppliers for sterile injectables system, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Sterile Injectables Market, By Molecule Type:
Large Molecules
Small Molecules
Global Sterile Injectables Market, By Drug Type:
Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others
Global Sterile Injectables Market, By Therapeutic Application:
Cancer
Metabolic Diseases
Cardiovascular Diseases
Central Nervous Systems Disorders
Infectious Disorders
Musculoskeletal Disorders
Others
Global Sterile Injectables Market, By Route of Administration:
Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others
Global Sterile Injectables Market, By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Global Sterile Injectables Market, By Region:
North America
By Molecule Type:
Large Molecules
Small Molecules
By Drug Type:
Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others
By Therapeutic Application:
Cancer
Metabolic Diseases
Cardiovascular Diseases
Central Nervous Systems Disorders
Infectious Disorders
Musculoskeletal Disorders
Others
By Route of Administration:
Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.S.
Canada
Europe
By Molecule Type:
Large Molecules
Small Molecules
By Drug Type:
Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others
By Therapeutic Application:
Cancer
Metabolic Diseases
Cardiovascular Diseases
Central Nervous Systems Disorders
Infectious Disorders
Musculoskeletal Disorders
Others
By Route of Administration:
Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Molecule Type:
Large Molecules
Small Molecules
By Drug Type:
Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others
By Therapeutic Application:
Cancer
Metabolic Diseases
Cardiovascular Diseases
Central Nervous Systems Disorders
Infectious Disorders
Musculoskeletal Disorders
Others
By Route of Administration:
Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Molecule Type:
Large Molecules
Small Molecules
By Drug Type:
Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others
By Therapeutic Application:
Cancer
Metabolic Diseases
Cardiovascular Diseases
Central Nervous Systems Disorders
Infectious Disorders
Musculoskeletal Disorders
Others
By Route of Administration:
Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Molecule Type:
Large Molecules
Small Molecules
By Drug Type:
Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others
By Therapeutic Application:
Cancer
Metabolic Diseases
Cardiovascular Diseases
Central Nervous Systems Disorders
Infectious Disorders
Musculoskeletal Disorders
Others
By Route of Administration:
Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East

Africa
By Molecule Type:
Large Molecules
Small Molecules
By Drug Type:
Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others
By Therapeutic Application:
Cancer
Metabolic Diseases
Cardiovascular Diseases
Central Nervous Systems Disorders
Infectious Disorders
Musculoskeletal Disorders
Others
By Route of Administration:
Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Baxter International Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Strategies
AstraZeneca plc
Merck & Co., Inc
Novartis AG
Johnson & Johnson Services, Inc
Gilead Sciences, Inc.
JHP Pharmaceuticals
Pfizer Inc.
Fresenius Kabi Ag
CordenPharma
Hikma Pharmaceuticals PLC.
“*” marked represents similar segmentation in other categories in the respective section.